HPV screening for women aged 23-29

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates whether organized screening using primary HPV analysis offers better cancer protection for women aged 23-29 compared to the traditional method of cytology. The study will involve women born between 1991 and 1997 in the Stockholm and Skåne regions of Sweden. Participants will undergo cell sampling and analysis to determine the effectiveness of HPV testing in preventing cervical cancer and related conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women ages 23-29 invited to screening.

Exclusion Criteria:

* Women who do not show up for screening or do not consent.

Where it's running

• Region Stockholm
  Stockholm, Sweden Recruiting
• Region of Skåne
  Lund, Skåne County, Sweden Active not recruiting

Study contacts

• Principal investigator: Joakim Dillner, MD, PhD — Karolinska University Hospital/Karolinska Institutet
• Study coordinator: Joakim Dillner, MD, PhD
• Email: joakim.dillner@ki.se
• Phone: +46 (0) 72-468 24 60

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CHW4CervixHealth: HPV self-collection kits with community health workers

  This project will test whether giving self-collection HPV kits during community workshops led by community health workers helps increase screening among under-screened women aged 25–65 and will first compare kit results to clinical Pap smears.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07336134

• HPV self-sampling to improve cervical screening for women in Zaporizhzhia during the war

  This project will test whether giving women aged 30–60 in Zaporizhzhia HPV self-sampling kits can keep cervical screening going when clinic access is disrupted by the war.

  Recruiting Karolinska Institutet · Zaporizhzhya · NCT07275333

• Investigating HPV and skin cancer risks in organ transplant recipients

  This study is trying to see if organ transplant recipients have a higher risk of HPV infections and skin cancer compared to people with normal immune systems.

  Recruiting at 3 sites Bispebjerg Hospital · Copenhagen NV, Capital Region and 2 other locations · NCT05284877

• Cervical screening and care options for women living with HIV who test positive for high-risk HPV

  This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.

  Recruiting University of California, San Diego · Nairobi · NCT07925307

• Hydrogel spacer to protect the rectum during cervical cancer radiotherapy

  This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07904182

• How cinema sessions during chemotherapy might help cervical cancer patients

  We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07902180

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.